OHLCX Market Research
Delayed

BIB

BIB, or ProShares Ultra Biotech, is an exchange-traded fund (ETF) designed to provide twice the daily return of the S&P Biotechnology Select Industry Index. It is a leveraged ETF, aiming to deliver 2x the daily performance of the underlying index.

−2.10 (−3.95%) Nov 20, 2026 17:50 ET Delayed
Open
53.10
High
54.00
Low
51.00
Prev close
53.10
Volume
41K
Avg vol 10
10K

Today · Market closed · opens Mon 9:30 AM

Price

BIB chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 51.00

Strong sellNeutralStrong buy
Sell
score −0.33 · 18 signalling
4Buy
4Neutral
10Sell

Leaning sell. 10 of 18 signals point down against 4 up, carried by momentum, trend and volume. Volatility leans buy. RSI, Stochastic, Stoch RSI, Williams %R and CCI sit in oversold territory.

How to read this →

Trend

MACD 12, 26, 9
Below signal line and zero
MACD −8.95 · Signal −1.71 · Hist −7.24
Sell
ADX 14
Developing trend, −DI ahead
ADX 21.39 · +DI 12.32 · −DI 64.37
Sell
Parabolic SAR 0.02, 0.2
Above price, 68.19 over the close
119.19
Sell
Ichimoku 9, 26, 52
Price below cloud, conversion below base
Conv 87.22 · Base 88.19 · A 108.29 · B 111.86
Sell

Momentum

RSI 14
Oversold, below 30
18.24
Buy
Stoch 14, 3
Oversold, %K still below %D
%K 0.00 · %D 0.73
Neutral
Stoch RSI 14, 14, 3, 3
Oversold, %K level with %D
%K 0.00 · %D 0.00
Neutral
Williams %R 14
Oversold zone, flat
−100.00
Neutral
CCI 14
Below −100, turning up
−236.95
Buy
MFI 14
Below midpoint, not oversold
21.28
Neutral
ROC 12
Price down 59.24% over 12 bars
−59.24%
Sell
AO 5, 35
Below zero and falling
−22.48
Sell
TRIX 18
Just below zero
−0.037
Sell
KST 10/15/20/30, 3
Below its signal line
KST −57.62 · Signal −4.47
Sell

Volatility

Bollinger 20, 2
Below the lower band
Up 150.87 · Mid 110.70 · Low 70.52
Buy
Keltner 20, 10, 1.5
Below the lower channel
Up 117.25 · Mid 103.78 · Low 90.32
Buy

Volume

VWAP 345-bar
Close 39.5% below VWAP
84.28
Sell
Force Index 1
Negative, sellers in control
−88.3K
Sell
ATR
7.88
15.44% of close
A/D Line
72.6K
cumulative
OBV
328.2K
cumulative
Volume Profile
76.32 – 81.89
POC · bull 601.7K · bear 639.1K · 48 / 52
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

-54.67%

Change in value over the past month.

3 month return

-57.69%

Change in value over the last three months.

Max drawdown

59.47%

Largest fall from a peak to the low that followed.

Standard deviation

72.52%

How far daily returns stray from their average, annualised.

Sharpe ratio

-0.21

Return above the risk-free rate per unit of volatility.

Calmar ratio

-0.26

Annualised return against the maximum drawdown.

About

BIB summary

Loading summary…

Questions

BIB, answered

What is the expense ratio of BIB?

BIB has an expense ratio of approximately 0.95%. This fee represents the cost of managing the fund, including administrative and operational expenses, and is expressed as a percentage of the fund’s average net assets.

Can BIB be used in a retirement account?

Yes, BIB can be held in retirement accounts such as IRAs or 401(k)s. However, due to its leveraged nature and higher risk profile, it’s important to consider how it fits within your overall investment strategy and risk tolerance.

What are the risks associated with investing in BIB?

Risks include high volatility and the potential for substantial losses due to the leveraged nature of the ETF. BIB’s performance is highly sensitive to daily changes in the biotech sector, and its use of leverage can amplify both gains and losses.

How is BIB managed?

BIB is managed by ProShares and seeks to achieve its investment objective by using financial instruments, including derivatives such as futures contracts, options, and swap agreements. It aims to provide leveraged exposure to the biotechnology sector.

What are the key performance metrics for BIB?

Key performance metrics for BIB include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. BIB's performance is designed to be twice that of the S&P Biotechnology Select Industry Index on a daily basis.

How often does BIB distribute dividends?

BIB typically distributes dividends on a quarterly basis. These dividends are generated from income produced by the underlying securities in the ETF, though leveraged ETFs may have lower yield compared to non-leveraged funds.

What is the historical performance of BIB?

Historical performance data for BIB includes past returns, NAV, and volatility. Investors should review performance charts and reports to understand how BIB has tracked its leveraged objective over different time periods.

How can I invest in BIB?

Investors can purchase shares of BIB through a brokerage account. It is traded on major stock exchanges under the ticker symbol "BIB" and can be bought and sold like other stocks and ETFs.

How does BIB handle index rebalancing or changes?

BIB rebalances its holdings daily to maintain its leverage ratio of 2x the daily performance of the S&P Biotechnology Select Industry Index. This daily rebalancing can lead to differences in performance over time compared to the index due to the effects of compounding.

What are some similar ETFs to BIB?

Similar ETFs to BIB include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide three times the daily performance of the S&P Biotechnology Select Industry Index; IBB (iShares Nasdaq Biotechnology ETF), which tracks the Nasdaq Biotechnology Index and provides exposure to biotechnology and pharmaceutical companies; and XBI (SPDR S&P Biotech ETF), which tracks the S&P Biotechnology Select Industry Index and provides broad exposure to the biotech sector.

Unlock Your BIB Trading Now

Achieve superior trading results with OHLCX Markets. Our platform provides expert analysis and actionable insights for BIB, utilizing the latest technology to refine your investment approach. Transform your trading strategy now now and see the impact on your trading success!

Boost Performance Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.